Financials
- Market Capitalization 2.45 B
- Employee 293
- Founded 2017
- CEO N/A
- Website www.harmonybiosciences.com
- Headquarter Delaware, United States
- FIGI BBG00WBPG4C2
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1846 | NKTR Nektar Therapeutics - Common Stock | 73.93 USD | -3.19% | +3.38% | +0.50% | +0.90% | 2.52 B USD | ||
| 1856 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 27.90 USD | -1.31% | +8.90% | +4.38% | -30.89% | 2.47 B USD | ||
| 1869 | TRVI Trevi Therapeutics, Inc. - Common Stock | 17.27 USD | +1.23% | +2.86% | -8.96% | +138.54% | 2.46 B USD | ||
| 1876 | NUVB Nuvation Bio Inc. Class A Common Stock | 6.81 USD | +0.59% | +1.64% | +5.09% | +95.69% | 2.39 B USD |
Frequently asked questions about Harmony Biosciences Holdings, Inc. Common Stock
What is the Harmony Biosciences Holdings, Inc. Common Stock stock price today?
The current price of Harmony Biosciences Holdings, Inc. Common Stock (HRMY) is 42.12. Over the past 24 hours, the stock has changed by +0.62%. Follow the HRMY chart for real-time price dynamics.
What is the stock ticker of Harmony Biosciences Holdings, Inc. Common Stock?
Harmony Biosciences Holdings, Inc. Common Stock trades under the ticker HRMY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Harmony Biosciences Holdings, Inc. Common Stock stock going up?
HRMY has changed by +7.15% over the last week, +8.61% over the last month, and +36.31% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Harmony Biosciences Holdings, Inc. Common Stock?
Harmony Biosciences Holdings, Inc. Common Stock currently has a market capitalization of 2.45 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Harmony Biosciences Holdings, Inc. Common Stock earnings last quarter?
Last quarter, Harmony Biosciences Holdings, Inc. Common Stock reported earnings of 1.3 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Harmony Biosciences Holdings, Inc. Common Stock revenue for the last quarter?
Harmony Biosciences Holdings, Inc. Common Stock reported quarterly revenue of 261.28 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Harmony Biosciences Holdings, Inc. Common Stock net income for the last quarter?
Harmony Biosciences Holdings, Inc. Common Stock reported net income of 75.43 M for the last quarter. The previous quarter showed 32.49 M, which means net income changed by +132.18%.
How many employees does Harmony Biosciences Holdings, Inc. Common Stock have?
As of the latest available data, Harmony Biosciences Holdings, Inc. Common Stock has 293 employees. Workforce size can provide additional context about the company's scale and operations.
What is Harmony Biosciences Holdings, Inc. Common Stock EBITDA?
Harmony Biosciences Holdings, Inc. Common Stock EBITDA is 95.01 M, and its EBITDA margin is 36.36%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Harmony Biosciences Holdings, Inc. Common Stock stock?
You can buy Harmony Biosciences Holdings, Inc. Common Stock (HRMY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Harmony Biosciences Holdings, Inc. Common Stock stock?
Investing in Harmony Biosciences Holdings, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the HRMY chart and related analysis on metatrader.com as part of your research.